Skip to content

Mindfulness-Based Stress Reduction in Somatic symptom disorder

Title: Effectiveness of Mindfulness-Based Stress Reduction (MBSR) Intervention on Psychological Symptoms, Quality of Life, Symptom Severity in Patients with Somatic Symptoms Disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180909040974N2
Enrollment
20
Registered
2020-08-01
Start date
2020-06-06
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

somatic symptom disorder. Fear of other medical care

Interventions

Intervention 1: Intervention group: The intervention group was treated with Venlafaxine, and they participated in eight 2-hour sessions of the Mindfulness Based Stress Reduction (MBSRD) program on a w

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Documented diagnosis of Somatic Symptom Disorder based on Diagnostic and Statistical Manual of psychiatric disorders Educational level more than primary school, Age between 20-50 years, Patient's willingness to participate in this study

Exclusion criteria

Exclusion criteria: Diagnosis of other major psychiatry disorder based on clinical interview and Substance use disorder Participating in another psychotherapy

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Before and 8 weeks after intervention. Method of measurement: Questionnaire of anxiety, depression, stress scale (DASS).

Secondary

MeasureTime frame
Quality of life. Timepoint: Before and 8 weeks after the intervention. Method of measurement: 36-Item Short Form Health Survey.;Clinical symptoms. Timepoint: Before and 8 weeks after the intervention. Method of measurement: Patient Health Questionnare 15-item.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Rahafrouz

Esfahan University of Medical Sciences

fatemehzargar@gmail.com+98 31 3792 8109

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026